These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34107682)

  • 1. Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors.
    Talukdar A; Ganguly D; Roy S; Das N; Sarkar D
    J Med Chem; 2021 Jun; 64(12):8010-8041. PubMed ID: 34107682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines.
    Kuznik A; Bencina M; Svajger U; Jeras M; Rozman B; Jerala R
    J Immunol; 2011 Apr; 186(8):4794-804. PubMed ID: 21398612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell Surface Expression of Endosomal Toll-Like Receptors-A Necessity or a Superfluous Duplication?
    Mielcarska MB; Bossowska-Nowicka M; Toka FN
    Front Immunol; 2020; 11():620972. PubMed ID: 33597952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM; Vollmer J
    Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic Acid Sensing by Toll-Like Receptors in the Endosomal Compartment.
    Miyake K; Shibata T; Fukui R; Sato R; Saitoh SI; Murakami Y
    Front Immunol; 2022; 13():941931. PubMed ID: 35812450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of nucleic acids by Toll-like receptors and development of immunomodulatory drugs.
    Kuznik A; Panter G; Jerala R
    Curr Med Chem; 2010; 17(18):1899-914. PubMed ID: 20377514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic Acid-Sensing Toll-Like Receptors Play a Dominant Role in Innate Immune Recognition of Pneumococci.
    Famà A; Midiri A; Mancuso G; Biondo C; Lentini G; Galbo R; Giardina MM; De Gaetano GV; Romeo L; Teti G; Beninati C
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209688
    [No Abstract]   [Full Text] [Related]  

  • 8. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of endosomal TLR agonists in viral disease.
    Averett DR; Fletcher SP; Li W; Webber SE; Appleman JR
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1468-72. PubMed ID: 18031247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor agonists are potent inhibitors of human immunodeficiency virus-type 1 replication in peripheral blood mononuclear cells.
    Buitendijk M; Eszterhas SK; Howell AL
    AIDS Res Hum Retroviruses; 2014 May; 30(5):457-67. PubMed ID: 24328502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9.
    Wang J; Shao Y; Bennett TA; Shankar RA; Wightman PD; Reddy LG
    J Biol Chem; 2006 Dec; 281(49):37427-34. PubMed ID: 17040905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Chaperone UNC93B1 Regulates Toll-like Receptor Stability Independently of Endosomal TLR Transport.
    Pelka K; Bertheloot D; Reimer E; Phulphagar K; Schmidt SV; Christ A; Stahl R; Watson N; Miyake K; Hacohen N; Haas A; Brinkmann MM; Marshak-Rothstein A; Meissner F; Latz E
    Immunity; 2018 May; 48(5):911-922.e7. PubMed ID: 29768176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor modulators: a patent review (2006-2010).
    Basith S; Manavalan B; Lee G; Kim SG; Choi S
    Expert Opin Ther Pat; 2011 Jun; 21(6):927-44. PubMed ID: 21406035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Toll' gates for future immunotherapy.
    Ishii KJ; Uematsu S; Akira S
    Curr Pharm Des; 2006; 12(32):4135-42. PubMed ID: 17100616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors and Type I interferons.
    Uematsu S; Akira S
    J Biol Chem; 2007 May; 282(21):15319-23. PubMed ID: 17395581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAGE Enhances TLR Responses through Binding and Internalization of RNA.
    Bertheloot D; Naumovski AL; Langhoff P; Horvath GL; Jin T; Xiao TS; Garbi N; Agrawal S; Kolbeck R; Latz E
    J Immunol; 2016 Nov; 197(10):4118-4126. PubMed ID: 27798148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists.
    Federico S; Pozzetti L; Papa A; Carullo G; Gemma S; Butini S; Campiani G; Relitti N
    J Med Chem; 2020 Nov; 63(22):13466-13513. PubMed ID: 32845153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical reagents modulate nucleic acid-activated toll-like receptors.
    Li X; Sun X; Guo X; Li X; Peng S; Mu X
    Biomed Pharmacother; 2022 Mar; 147():112622. PubMed ID: 35008000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic control of nucleic-acid-sensing Toll-like receptors by the endosomal compartment.
    Miyake K; Saitoh SI; Fukui R; Shibata T; Sato R; Murakami Y
    Int Immunol; 2021 Nov; 33(12):835-840. PubMed ID: 34223897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.